Sumitovant Biopharma Ltd.
-
Ticker
Exchange
-
Industry
Drug Manufacturers - Other More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Osaka, Japan
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.
SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including
…More Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company.
Sumitovant Biopharma Ltd.
Most Recent Responsibility Report
MOST RECENT
2023 Responsibility Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Sumitovant Biopharma Ltd. Sustainability Report, Sumitovant Biopharma Ltd. Corporate Social Responsibility Report, Sumitovant Biopharma Ltd. CSR Report, Sumitovant Biopharma Ltd. Corporate Responsibility, Sumitovant Biopharma Ltd. CR Report, Sumitovant Biopharma Ltd. Citizenship Report, Sumitovant Biopharma Ltd. ESG Report, and Sumitovant Biopharma Ltd. Environmental Report online.